Multicentric, surveillance study to monitor safety and reactogenicity of GSK Biologicals' purified meningococcal polysaccharide vaccine of serogroups ACWY in 3,000 Filipino subjects aged greater than 2 years when administered according to the prescribing information.
Phase of Trial: Phase IV
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 polysaccharide (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions; Registrational
- Sponsors GlaxoSmithKline
- 02 Nov 2008 Actual patient number (249) added as reported by ClinicalTrials.gov.
- 17 Jul 2008 GlaxoSmithKline Biologicals reported as trial affliate by ClinicalTrials.gov.
- 17 Jul 2008 The expected completion date for this trial is added (Oct 2006) as reported by ClinicalTrials.gov.